Приказ основних података о документу

dc.creatorLupattelli, Angela
dc.creatorSpigset, Olav
dc.creatorBjoernsdottir, Ingunn
dc.creatorHaemeen-Anttila, Katri
dc.creatorMardby, Ann-Charlotte
dc.creatorPanchaud, Alice
dc.creatorJuraski, Romana Gjergja
dc.creatorRudolf, Gorazd
dc.creatorOdalović, Marina
dc.creatorDrozd, Mariola
dc.creatorTwigg, Michael J.
dc.creatorJuch, Herbert
dc.creatorMoretti, Myla E.
dc.creatorKennedy, Debra
dc.creatorRieutord, Andre
dc.creatorZagorodnikova, Ksenia
dc.creatorPassier, Anneke
dc.creatorNordeng, Hedvig
dc.date.accessioned2019-09-02T11:46:53Z
dc.date.available2019-09-02T11:46:53Z
dc.date.issued2015
dc.identifier.issn1091-4269
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/2397
dc.description.abstractBackgroundNo previous studies have explored how closely women follow their psychotropic drug regimens during pregnancy. This study aimed to explore patterns of and factors associated with low adherence to psychotropic medication during pregnancy. MethodsMultinational web-based study was performed in 18 countries in Europe, North America, and Australia. Uniform data collection was ensured via an electronic questionnaire. Pregnant women were eligible to participate. Adherence was measured via the 8-item Morisky Medication Adherence Scale (MMAS-8). The Beliefs about Prescribed Medicines Questionnaire (BMQ-specific), the Edinburgh Postnatal Depression Scale (EPDS), and a numeric rating scale were utilized to measure women's beliefs, depressive symptoms, and antidepressant risk perception, respectively. Participants reporting use of psychotropic medication during pregnancy (n = 160) were included in the analysis. ResultsOn the basis of the MMAS-8, 78 of 160 women (48.8%, 95% CI: 41.1-56.4%) demonstrated low adherence during pregnancy. The rates of low adherence were 51.3% for medication for anxiety, 47.2% for depression, and 42.9% for other psychiatric disorders. Smoking during pregnancy, elevated antidepressant risk perception (risk6), and depressive symptoms were associated with a significant 3.9-, 2.3-, and 2.5-fold increased likelihood of low medication adherence, respectively. Women on psychotropic polytherapy were less likely to demonstrate low adherence. The belief that the benefit of pharmacotherapy outweighed the risks positively correlated (r = .282) with higher medication adherence. ConclusionsApproximately one of two pregnant women using psychotropic medication demonstrated low adherence in pregnancy. Life-style factors, risk perception, depressive symptoms, and individual beliefs are important factors related to adherence to psychotropic medication in pregnancy.en
dc.publisherWiley, Hoboken
dc.rightsrestrictedAccess
dc.sourceDepression and Anxiety
dc.subjectadherenceen
dc.subjectpharmacotherapyen
dc.subjectantidepressantsen
dc.subjectdepressionen
dc.subjectanxietyen
dc.subjectpregnancyen
dc.titlePatterns and factors associated with low adherence to psychotropic medications during pregnancy - A cross-sectional, multinational web-based studyen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractПассиер, Aннеке; Моретти, Мyла Е.; Јуцх, Херберт; Рудолф, Горазд; Хаемеен-Aнттила, Катри; Бјоернсдоттир, Ингунн; Спигсет, Олав; Панцхауд, Aлице; Лупаттелли, Aнгела; Јураски, Романа Гјергја; Одаловић, Марина; Риеуторд, Aндре; Тwигг, Мицхаел Ј.; Мардбy, Aнн-Цхарлотте; Дрозд, Мариола; Загородникова, Ксениа; Норденг, Хедвиг; Кеннедy, Дебра;
dc.citation.volume32
dc.citation.issue6
dc.citation.spage426
dc.citation.epage436
dc.citation.other32(6): 426-436
dc.citation.rankaM21
dc.identifier.wos000354568500006
dc.identifier.doi10.1002/da.22352
dc.identifier.pmid25703355
dc.identifier.scopus2-s2.0-84929504965
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу